Incipiam Pharma ApS — Credit Rating and Financial Key Figures

Incipiam Pharma ApS (CVR number: 44074214) is a company from KØBENHAVN. The company recorded a gross profit of -1201.2 kDKK in 2025. The operating profit was -1953.9 kDKK, while net earnings were -1847.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -24.4 %, which can be considered poor and Return on Equity (ROE) was -27.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -18.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Incipiam Pharma ApS's liquidity measured by quick ratio was 4 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.